Literature DB >> 19033999

Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV.

Staci A Fischer1.   

Abstract

Transplant physicians and surgeons are familiar with the risks, clinical behavior, and management of cytomegalovirus in transplant recipients. Donor-transmitted viral infections are uncommon but in recent years have brought to light the clinical manifestations of rabies, West Nile virus, and lymphocytic choriomeningitis virus in the early posttransplant period. Later posttransplant, infection with viruses circulating in the community can occur with a number of pathogens, including some vaccine-preventable illnesses such as measles and mumps. Recent advances in molecular microbiology have made it possible to diagnose a growing number of community-acquired viral pathogens infecting transplant recipients. This article reviews some of the emerging and reemerging viral pathogens infecting solid organ and hematopoietic stem-cell recipients, including adenovirus, bocavirus, coronavirus, human herpesvirus-6, lymphocytic choriomeningitis virus, measles, mumps, metapneumovirus, parainfluenza, rotavirus, respiratory syncytial virus, and West Nile virus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19033999     DOI: 10.1097/TP.0b013e31818b6548

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  29 in total

1.  Adenovirus Modulates Toll-Like Receptor 4 Signaling by Reprogramming ORP1L-VAP Protein Contacts for Cholesterol Transport from Endosomes to the Endoplasmic Reticulum.

Authors:  Nicholas L Cianciola; Stacey Chung; Danny Manor; Cathleen R Carlin
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

Review 2.  Systems analysis of West Nile virus infection.

Authors:  Mehul S Suthar; Bali Pulendran
Journal:  Curr Opin Virol       Date:  2014-05-20       Impact factor: 7.090

Review 3.  Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?

Authors:  Henry F Vischer; Marco Siderius; Rob Leurs; Martine J Smit
Journal:  Nat Rev Drug Discov       Date:  2014-01-21       Impact factor: 84.694

Review 4.  Monitoring and managing viral infections in pediatric renal transplant recipients.

Authors:  Patrizia Comoli; Fabrizio Ginevri
Journal:  Pediatr Nephrol       Date:  2011-02-26       Impact factor: 3.714

Review 5.  Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation.

Authors:  Andrés Server; Nuria Bargalló; Yngvar Fløisand; Jon Sponheim; Francesc Graus; John K Hald
Journal:  Neuroradiology       Date:  2017-03-02       Impact factor: 2.804

Review 6.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

7.  Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation.

Authors:  Ryan M Kelly; Emily M Goren; Patricia A Taylor; Scott N Mueller; Heather E Stefanski; Mark J Osborn; Hamish S Scott; Elena A Komarova; Andrei V Gudkov; Georg A Holländer; Bruce R Blazar
Journal:  Blood       Date:  2009-12-04       Impact factor: 22.113

8.  IPS-1 is essential for the control of West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Daphne Y Ma; Sunil Thomas; Jennifer M Lund; Nu Zhang; Stephane Daffis; Alexander Y Rudensky; Michael J Bevan; Edward A Clark; Murali-Krishna Kaja; Michael S Diamond; Michael Gale
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

9.  Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients.

Authors:  Cedar J Fowler; Jennifer Dunlap; Darcy Troyer; Peter Stenzel; Elliot Epner; Richard T Maziarz
Journal:  Adv Hematol       Date:  2010-06-16

10.  Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506).

Authors:  Biagio De Angelis; Gianpietro Dotti; Concetta Quintarelli; Leslie E Huye; Lan Zhang; Ming Zhang; Fabrizio Pane; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney; Barbara Savoldo
Journal:  Blood       Date:  2009-09-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.